23.99 USD
+0.01 (+0.04%)
23.99 USD
0 (0%)
Taking everything into account, ABCM scores 5 out of 10 in our fundamental rating. ABCM was compared to 528 industry peers in the Biotechnology industry. ABCM has only an average score on both its financial health and profitability. ABCM is not priced too expensively while it is growing strongly. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
- In the past year ABCM was profitable.
- In the past year ABCM had a positive cash flow from operations.
1.2 Ratios
- ABCM's Return On Assets of 0.64% is amongst the best of the industry. ABCM outperforms 93.86% of its industry peers.
- ABCM has a better Return On Equity (0.93%) than 93.86% of its industry peers.
- ABCM has a better Return On Invested Capital (1.98%) than 94.69% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for ABCM is significantly below the industry average of 18.28%.
- The last Return On Invested Capital (1.98%) for ABCM is well below the 3 year average (6.00%), which needs to be investigated, but indicates that ABCM had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.64% | ||
| ROE | 0.93% | ||
| ROIC | 1.98% |
ROA(3y)4.53%
ROA(5y)8.06%
ROE(3y)5.58%
ROE(5y)9.64%
ROIC(3y)6%
ROIC(5y)8.74%
1.3 Margins
- ABCM has a Profit Margin of 1.94%. This is amongst the best in the industry. ABCM outperforms 94.86% of its industry peers.
- ABCM's Profit Margin has declined in the last couple of years.
- With an excellent Operating Margin value of 8.70%, ABCM belongs to the best of the industry, outperforming 95.36% of the companies in the same industry.
- In the last couple of years the Operating Margin of ABCM has declined.
- ABCM has a Gross Margin of 72.69%. This is amongst the best in the industry. ABCM outperforms 83.58% of its industry peers.
- ABCM's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.7% | ||
| PM (TTM) | 1.94% | ||
| GM | 72.69% |
OM growth 3Y-28.84%
OM growth 5Y-15.57%
PM growth 3Y-41.13%
PM growth 5Y-24.24%
GM growth 3Y0.59%
GM growth 5Y0.27%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ABCM is destroying value.
- The number of shares outstanding for ABCM has been increased compared to 1 year ago.
- Compared to 1 year ago, ABCM has an improved debt to assets ratio.
2.2 Solvency
- ABCM has an Altman-Z score of 8.64. This indicates that ABCM is financially healthy and has little risk of bankruptcy at the moment.
- ABCM has a better Altman-Z score (8.64) than 85.41% of its industry peers.
- ABCM has a debt to FCF ratio of 19.99. This is a negative value and a sign of low solvency as ABCM would need 19.99 years to pay back of all of its debts.
- ABCM's Debt to FCF ratio of 19.99 is amongst the best of the industry. ABCM outperforms 94.03% of its industry peers.
- A Debt/Equity ratio of 0.30 indicates that ABCM is not too dependend on debt financing.
- The Debt to Equity ratio of ABCM (0.30) is worse than 71.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 19.99 | ||
| Altman-Z | 8.64 |
ROIC/WACC0.22
WACC8.89%
2.3 Liquidity
- ABCM has a Current Ratio of 1.26. This is a normal value and indicates that ABCM is financially healthy and should not expect problems in meeting its short term obligations.
- ABCM's Current ratio of 1.26 is on the low side compared to the rest of the industry. ABCM is outperformed by 86.73% of its industry peers.
- A Quick Ratio of 0.98 indicates that ABCM may have some problems paying its short term obligations.
- With a Quick ratio value of 0.98, ABCM is not doing good in the industry: 88.56% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.98 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 402.64% over the past year.
- Measured over the past years, ABCM shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -17.30% on average per year.
- ABCM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.70%.
- The Revenue has been growing by 11.64% on average over the past years. This is quite good.
EPS 1Y (TTM)402.64%
EPS 3Y-38.1%
EPS 5Y-17.3%
EPS Q2Q%191.67%
Revenue 1Y (TTM)17.7%
Revenue growth 3Y8.48%
Revenue growth 5Y11.64%
Sales Q2Q%23.3%
3.2 Future
- The Earnings Per Share is expected to grow by 40.12% on average over the next years. This is a very strong growth
- The Revenue is expected to grow by 11.28% on average over the next years. This is quite good.
EPS Next Y125.95%
EPS Next 2Y68.04%
EPS Next 3Y52.49%
EPS Next 5Y40.12%
Revenue Next Year24.37%
Revenue Next 2Y18.92%
Revenue Next 3Y16.75%
Revenue Next 5Y11.28%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
- ABCM is valuated quite expensively with a Price/Earnings ratio of 44.43.
- ABCM's Price/Earnings ratio is rather cheap when compared to the industry. ABCM is cheaper than 94.69% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 27.47, ABCM is valued quite expensively.
- The Price/Forward Earnings ratio is 49.32, which means the current valuation is very expensive for ABCM.
- Based on the Price/Forward Earnings ratio, ABCM is valued cheaper than 94.53% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of ABCM to the average of the S&P500 Index (24.26), we can say ABCM is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.43 | ||
| Fwd PE | 49.32 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, ABCM is valued cheaper than 94.20% of the companies in the same industry.
- ABCM's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ABCM is cheaper than 93.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 374.67 | ||
| EV/EBITDA | 55.61 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- The decent profitability rating of ABCM may justify a higher PE ratio.
- A more expensive valuation may be justified as ABCM's earnings are expected to grow with 52.49% in the coming years.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y68.04%
EPS Next 3Y52.49%
5. Dividend
5.1 Amount
- ABCM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
23.99
+0.01 (+0.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)09-12 2022-09-12/dmh
Earnings (Next)N/A N/A
Inst Owners1.79%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.49B
Revenue(TTM)350.40M
Net Income(TTM)6.80M
Analysts80
Price Target20.23 (-15.67%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.43 | ||
| Fwd PE | 49.32 | ||
| P/S | 12.3 | ||
| P/FCF | 374.67 | ||
| P/OCF | 79.64 | ||
| P/B | 5.92 | ||
| P/tB | 42.37 | ||
| EV/EBITDA | 55.61 |
EPS(TTM)0.54
EY2.25%
EPS(NY)0.49
Fwd EY2.03%
FCF(TTM)0.06
FCFY0.27%
OCF(TTM)0.3
OCFY1.26%
SpS1.95
BVpS4.05
TBVpS0.57
PEG (NY)0.35
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.64% | ||
| ROE | 0.93% | ||
| ROCE | 3.54% | ||
| ROIC | 1.98% | ||
| ROICexc | 2.23% | ||
| ROICexgc | 7.95% | ||
| OM | 8.7% | ||
| PM (TTM) | 1.94% | ||
| GM | 72.69% | ||
| FCFM | 3.28% |
ROA(3y)4.53%
ROA(5y)8.06%
ROE(3y)5.58%
ROE(5y)9.64%
ROIC(3y)6%
ROIC(5y)8.74%
ROICexc(3y)7.76%
ROICexc(5y)11.54%
ROICexgc(3y)24.8%
ROICexgc(5y)47.7%
ROCE(3y)9.88%
ROCE(5y)14%
ROICexgc growth 3Y-57.08%
ROICexgc growth 5Y-37.19%
ROICexc growth 3Y-42.21%
ROICexc growth 5Y-23.94%
OM growth 3Y-28.84%
OM growth 5Y-15.57%
PM growth 3Y-41.13%
PM growth 5Y-24.24%
GM growth 3Y0.59%
GM growth 5Y0.27%
F-Score5
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 19.99 | ||
| Debt/EBITDA | 2.79 | ||
| Cap/Depr | 90.64% | ||
| Cap/Sales | 12.16% | ||
| Interest Coverage | 9.53 | ||
| Cash Conversion | 69.81% | ||
| Profit Quality | 169.12% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.98 | ||
| Altman-Z | 8.64 |
F-Score5
WACC8.89%
ROIC/WACC0.22
Cap/Depr(3y)181.11%
Cap/Depr(5y)191.67%
Cap/Sales(3y)16.16%
Cap/Sales(5y)14.67%
Profit Quality(3y)125.12%
Profit Quality(5y)105.69%
High Growth Momentum
Growth
EPS 1Y (TTM)402.64%
EPS 3Y-38.1%
EPS 5Y-17.3%
EPS Q2Q%191.67%
EPS Next Y125.95%
EPS Next 2Y68.04%
EPS Next 3Y52.49%
EPS Next 5Y40.12%
Revenue 1Y (TTM)17.7%
Revenue growth 3Y8.48%
Revenue growth 5Y11.64%
Sales Q2Q%23.3%
Revenue Next Year24.37%
Revenue Next 2Y18.92%
Revenue Next 3Y16.75%
Revenue Next 5Y11.28%
EBIT growth 1Y-18.45%
EBIT growth 3Y-22.8%
EBIT growth 5Y-5.74%
EBIT Next Year197.84%
EBIT Next 3Y63.16%
EBIT Next 5Y39.34%
FCF growth 1Y-42.5%
FCF growth 3Y-17.2%
FCF growth 5Y-14.26%
OCF growth 1Y66.98%
OCF growth 3Y4.34%
OCF growth 5Y8.73%
ABCAM PLC-SPON ADR / ABCM FAQ
Can you provide the ChartMill fundamental rating for ABCAM PLC-SPON ADR?
ChartMill assigns a fundamental rating of 6 / 10 to ABCM.
Can you provide the valuation status for ABCAM PLC-SPON ADR?
ChartMill assigns a valuation rating of 7 / 10 to ABCAM PLC-SPON ADR (ABCM). This can be considered as Undervalued.
What is the profitability of ABCM stock?
ABCAM PLC-SPON ADR (ABCM) has a profitability rating of 8 / 10.
What is the valuation of ABCAM PLC-SPON ADR based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ABCAM PLC-SPON ADR (ABCM) is 44.43 and the Price/Book (PB) ratio is 5.92.
What is the earnings growth outlook for ABCAM PLC-SPON ADR?
The Earnings per Share (EPS) of ABCAM PLC-SPON ADR (ABCM) is expected to grow by 125.95% in the next year.